Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9185883 | 0.87 | KMT2A (0.56) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL29757979 | 0.82 | TGM2 (0.46) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL30388557 | 0.81 | KCNMA1 (0.63) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL249599 | 0.81 | KCNMA1 (0.56) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL5144247 | 0.81 | KCNMA1 (0.63) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL505372 | 0.79 | KCNMA1 (0.51) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL9872830 | 0.79 | MEN1 (0.50) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL601548 | 0.79 | KMT2A (0.50) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL3412286 | 0.79 | MEN1 (0.50) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 | |
| SCHEMBL30625900 | 0.79 | KMT2A (0.50) | KMT2AMEN1POLBSMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730102-B1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | COUNCIL SCIENT IND RES (IN) | 2010-09-22 | — | — | EP | claimed |
| EP-1730102-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | Council of Scientific and Industrial Research (IN) | 2006-12-13 | — | — | EP | claimed |
| US-6979749-B2 | Catalytic process for the production of 3,3′, 4,4′-tetraminobiphenyl | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-12-27 | — | — | US | claimed |
| WO-2005092839-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-10-06 | — | — | WO | claimed |
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-09-29 | — | — | US | claimed |
| EP-1730102-B1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | COUNCIL SCIENT IND RES (IN) | 2010-09-22 | — | — | EP | disclosed |
| EP-1730102-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3 , 4,4'-TETRAMINOBIPHENYL | Council of Scientific and Industrial Research (IN) | 2006-12-13 | — | — | EP | disclosed |
| US-6979749-B2 | Catalytic process for the production of 3,3′, 4,4′-tetraminobiphenyl | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-12-27 | — | — | US | disclosed |
| WO-2005092839-A1 | A NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-10-06 | — | — | WO | disclosed |
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215823-A1 | NOVEL CATALYTIC PROCESS FOR THE PRODUCTION OF 3,3', 4,4'-TETRAMINOBIPHENYL | NNMT, CBR3, POR | KMT2A 130/4885MEN1 2108/4885POLB 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.